Quantitative Analysis of Acetaminophen and its Primary Metabolites in Small Plasma Volumes by Liquid Chromatography-Tandem Mass Spectrometry

Journal of Analytical Toxicology

Volumn 37, Issue 2, 2013, Pages 110-116

  Gicquel, Thomas ^a,b   Aubert, Jacinthe ^a   Lepage, Sylvie ^b   Fromenty, Bernard ^a   Morel, Isabelle ^a,b  

^a UNIVERSITÉ DE RENNES 1   (France)

^b PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PARACETAMOL;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALIBRATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG STRUCTURE; DRUG TRANSFORMATION; ELECTROSPRAY; FEMALE; GLUCURONIDATION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; LIVER DISEASE; MOUSE; NONHUMAN; OBESITY; QUADRUPOLE MASS SPECTROMETRY; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ANIMALS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FATTY LIVER; FEMALE; GLUCURONIDES; HUMANS; MICE; MICE, INBRED C57BL; MICE, OBESE; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SULFATES; TANDEM MASS SPECTROMETRY;

EID: 84873644755     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bks139     Document Type: Article

References (31)

1. Prescott, L.F. (1980) Kinetics and metabolism of paracetamol and phenacetin. British Journal of Clinical Pharmacology, 10, 291S-298S.
2. Dahlin, D.C., Miwa, G.T., Lu, A.Y., Nelson, S.D. (1984) N-acetyl-p-benzoquinone imine: A cytochrome P-450-mediated oxidation product of acetaminophen. Proceedings of the National Academy of Science of the USA, 81, 1327-1331.
3. Laine, J.E., Auriola, S., Pasanen, M., Juvonen, R.O. (2009) Acetaminophen bioactivation by human cytochrome P450 enzymes and animal microsomes. Xenobiotica, 39, 11-21.
4. Hosomi, H., Fukami, T., Iwamura, A., Nakajima, M., Yokoi, T. (2011) Development of a highly sensitive cytotoxicity assay system for CYP3A4-mediated metabolic activation. Drug Metabolism and Disposition, 39, 1388-1395.
5. Abdelmegeed, M.A., Moon, K.H., Chen, C., Gonzalez, F.J., Song, B.J. (2010) Role of cytochrome P450 2E1 in protein nitration and ubiquitin-mediated degradation during acetaminophen toxicity. Biochemical Pharmacology, 79, 57-66.
6. Larson, A.M., Polson, J., Fontana, R.J., Davern, T.J., Lalani, E., Hynan, L.S. et al. (2005) Acetaminophen-induced acute liver failure: Results of a United States multicenter, prospective study. Hepatology, 42, 1364-1372.
7. Craig, D.G., Bates, C.M., Davidson, J.S., Martin, K.G., Hayes, P.C., Simpson, K.J. (2012) Staggered overdose pattern and delay to hospital presentation are associated with adverse outcomes following paracetamol-induced hepatotoxicity. British Journal of Clinical Pharmacology, 73, 285-294.
8. Nguyen, G.C., Sam, J., Thuluvath, P.J. (2008) Hepatitis C is a predictor of acute liver injury among hospitalizations for acetaminophen overdose in the United States: a nationwide analysis. Hepatology, 48, 1336-1341.
9. Myers, R.P., Shaheen, A.A. (2009) Hepatitis C, alcohol abuse, and unintentional overdoses are risk factors for acetaminophen-related hepatotoxicity. Hepatology, 49, 1399-1400.
10. Watkins, P.B., Kaplowitz, N., Slattery, J.T., Colonese, C.R., Colucci, S.V., Stewart, P.W. et al. (2006) Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. Journal of the American Medical Association, 296, 87-93.
11. Winnike, J.H., Li, Z., Wright, F.A., Macdonald, J.M., O'Connell, T.M., Watkins, P.B. (2010) Use of pharmaco-metabonomics for early prediction of acetaminophen-induced hepatotoxicity in humans. Clinical Pharmacology and Therapeutics, 88, 45-51.
12. Ryan, P.M., Bourdi, M., Korrapati, M.C., Proctor, W.R., Vasquez, R.A., Yee, S.B. et al. (2012) Endogenous interleukin-4 regulates glutathione synthesis following acetaminophen-induced liver injury in mice. Chemical Research in Toxicology, 25, 83-93.
13. Ni, H.M., Bockus, A., Boggess, N., Jaeschke, H., Ding, W.X. (2012) Activation of autophagy protects against acetaminophen-induced hepatotoxicity. Hepatology, 55, 222-232.
14. Sparkenbaugh, E.M., Saini, Y., Greenwood, K.K., LaPres, J.J., Luyendyk, J.P., Copple, B.L. et al. (2011) The role of hypoxia induciblefactor-1a in acetaminophen hepatotoxicity. Journal of Pharmacology and Experimental Therapeutics, 338, 492-502.
15. Lee, W.H., Kramer, W.G., Granville, G.E. (1981) The effect of obesity on acetaminophen pharmacokinetics in man. Journal of Clinical Pharmacology, 21, 284-287.
16. Abernethy, D.R., Greenblatt, D.J., Divoll, M., Shader, R.I. (1983) Enhanced glucuronide conjugation of drugs in obesity: studies of lorazepam, oxazepam, and acetaminophen. Journal of Laboratory and Clinical Medicine, 101, 873-880.
17. Barshop, N.J., Capparelli, E.V., Sirlin, C.B., Schwimmer, J.B., Lavine, J.E. (2011) Acetaminophen pharmacokinetics in children with nonalcoholic fatty liver disease. Journal of Pediatriatric Gastroenterolology and Nutrition, 52, 198-202.
18. Colin, P., Sirois, G., Chakrabarti, S. (1987) Rapid highperformance liquid chromatographic assay of acetaminophen in serum and tissue homogenates. Journal of Chromatography B, 413, 151-160.
19. Kulkarni, S.G., Pegram, A.A., Smith, P.C. (2000) Disposition of acetaminophen and indocyanine green in cystic fibrosis-knockout mice. AAPS Pharmaceutical Science, 2, E18.
20. Vertzoni, M.V., Archontaki, H.A., Galanopoulou, P. (2003) Development and optimization of a reversed-phase highperformance liquid chromatographic method for the determination of acetaminophen and its major metabolites in rabbit plasma and urine after a toxic dose. Journal of Pharmaceutical and Biomedical Analysis, 32, 487-493.
21. Flores-Pé Rez, C., Chávez-Pacheco, J.L., Rami{dotless}́Rez-Mendiola, B., Alemó n-Medina, R., Garci{dotless}́a-Á lvarez, R., Juárez-Olgui{dotless}́n, H. et al. (2011) A reliable method of liquid chromatography for the quantification of acetaminophen and identification of its toxic metabolite N-acetyl-p-benzoquinoneimine for application in pediatric studies. Biomedical Chromatography, 25, 760-766.
22. An, J.H., Lee, H.J., Jung, B.H. (2012) Quantitative analysis of acetaminophen and its six metabolites in rat plasma using liquid chromatography/tandem mass spectrometry; Biomedical Chromatography, 12, 1596-1604.
23. Chen, C., Hennig, G., Manautou, J. (2003) Hepatobiliary excretion of acetaminophen glutatione conjugate and its derivatives in transportdeficient (TR-) hyperbilirubinemic rats. Drug Metabolism and Disposition, 31, 798-804.
24. Li, H., Zhang, C., Wang, J., Jiang, Y., Fawcett, J.P., Gu, J. (2010) Simultaneous quantitation of paracetamol, caffeine, pseudoephedrine, chlorpheniramine and cloperastine in human plasma by liquid chromatography-tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis, 51, 716-722.
25. Mannery, Y.O., Ziegler, T.R., Park, Y., Jones, D.P. (2010) Acetaminophen elimination half-life in humans is unaffected by short-term consumption of sulfur amino acid-free diet. Journal of Pharmacology and Experimental Therapeutics, 333, 948-953.
26. Hewavitharana, A.K., Lee, S., Dawson, P.A., Markovich, D., Shaw, P.N. (2008) Development of an HPLC-MS/MS method for the selective determination of paracetamol metabolites in mouse urine. Analytical Biochemistry, 374, 106-111.
27. Van Eeckhaut, A., Lanckmans, K., Sarre, S., Smolders, I., Michotte, Y. (2009) Validation of bioanalytical LC-MS/MS assays: Evaluation of matrix effects. Journal of Chromatography B, 877, 2198-2207.
28. Tan, Q.Y., Zhu, R.H., Li, H.D., Wang, F., Yan, M., Dai, L.B. (2012) Simultaneous quantitative determination of paracetamol and its glucuronide conjugate in human plasma and urine by liquid chromatography coupled to electrospray tandem mass spectrometry: Application to a clinical pharmacokinetic study. Journal of Chromatography B, 162, 893-894.
29. Xu, J., Kulkarni, S.R., Li, L., Slitt, A.L. (2012) UDP-Glucuronosyltransferase expression in mouse liver is increased in obesity- and fasting-induced steatosis. Drug Metabolism and Disposition, 40, 259-266.
30. Aubert, J., Begriche, K., Delannoy, M., Morel, I., Pajaud, J., Ribault, C. et al. Differences in early acetaminophen hepatotoxicity between obese ob/ob and db/db mice. (2012) Journal of Pharmacology and Experimental Therapeutics, 342, 676-687.
31. Aubert, J., Begriche, K., Knockaert, L., Robin, M.A., Fromenty, B. (2011) Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: Mechanisms and pathophysiological role. Clinical Research in Hepatology and Gastroenterology, 35, 630-637.